DK1534741T3 - Fiberformende peptider i stand til at interagere med selvsamlende peptider - Google Patents

Fiberformende peptider i stand til at interagere med selvsamlende peptider

Info

Publication number
DK1534741T3
DK1534741T3 DK03793920T DK03793920T DK1534741T3 DK 1534741 T3 DK1534741 T3 DK 1534741T3 DK 03793920 T DK03793920 T DK 03793920T DK 03793920 T DK03793920 T DK 03793920T DK 1534741 T3 DK1534741 T3 DK 1534741T3
Authority
DK
Denmark
Prior art keywords
peptides
fiber
interacting
self
forming
Prior art date
Application number
DK03793920T
Other languages
English (en)
Inventor
Derek Woolfson
Maxim G Ryadnov
Original Assignee
Univ Sussex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Sussex filed Critical Univ Sussex
Application granted granted Critical
Publication of DK1534741T3 publication Critical patent/DK1534741T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nanotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Multicomponent Fibers (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
DK03793920T 2002-09-06 2003-09-08 Fiberformende peptider i stand til at interagere med selvsamlende peptider DK1534741T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0220805.6A GB0220805D0 (en) 2002-09-06 2002-09-06 Peptide monomers and protein structures
PCT/GB2003/003900 WO2004022584A1 (en) 2002-09-06 2003-09-08 Fiber-shaping peptides capable of interacting with self-assembling peptides

Publications (1)

Publication Number Publication Date
DK1534741T3 true DK1534741T3 (da) 2008-12-15

Family

ID=9943665

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03793920T DK1534741T3 (da) 2002-09-06 2003-09-08 Fiberformende peptider i stand til at interagere med selvsamlende peptider

Country Status (9)

Country Link
US (1) US7507790B2 (da)
EP (1) EP1534741B1 (da)
JP (1) JP4544997B2 (da)
AT (1) ATE404581T1 (da)
AU (1) AU2003264736A1 (da)
DE (1) DE60322913D1 (da)
DK (1) DK1534741T3 (da)
GB (1) GB0220805D0 (da)
WO (1) WO2004022584A1 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201306634D0 (en) 2013-04-11 2013-05-29 Univ Bristol Cage-like particles
WO2016129656A1 (ja) * 2015-02-12 2016-08-18 国立大学法人岩手大学 哺乳動物細胞に対する外来遺伝子の導入効率の向上剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5955343A (en) * 1992-12-28 1999-09-21 Massachusetts Institute Of Technology Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor
GB9922013D0 (en) * 1999-09-17 1999-11-17 Univ Sussex Peptides

Also Published As

Publication number Publication date
US20060155112A1 (en) 2006-07-13
ATE404581T1 (de) 2008-08-15
US7507790B2 (en) 2009-03-24
WO2004022584A1 (en) 2004-03-18
EP1534741B1 (en) 2008-08-13
AU2003264736A1 (en) 2004-03-29
GB0220805D0 (en) 2002-10-16
JP4544997B2 (ja) 2010-09-15
JP2006513985A (ja) 2006-04-27
EP1534741A1 (en) 2005-06-01
DE60322913D1 (de) 2008-09-25

Similar Documents

Publication Publication Date Title
DK1511761T3 (da) Fremgangsmåde til fremstilling af cykliske peptider
CY1119106T1 (el) Αντισωματα εναντι masp-2
ATE259782T1 (de) N-cyanomethylamide als protease-inhibitoren
EA200700255A1 (ru) Новый карбамилированный еро и способ его получения
ATE549028T1 (de) Stabile analoga von glp-1
WO2004099231A3 (en) Glycopegylation methods and proteins/peptides produced by the methods
CY1108602T1 (el) Μεθοδος καθαρισμου της fsh
MXPA05003730A (es) Eritropoyetina: remodelado y glicoconjugacion de eritropoyetina.
BR0308452A (pt) composições farmacêuticas e métodos de preparação de composição farmacêutica
YU9404A (sh) Multimerna, usmerena kontrastna sredstva na bazi peptida
DE60315368D1 (de) Korrektur des Weissabgleichs
MXPA04003333A (es) Remodelado y glicoconjugacion de peptidos.
NO20031859L (no) Sementblanding
DE602005008996D1 (de) Radiofluorierte peptide
BRPI0414592A (pt) antagonistas de receptores de trombina
EA200971129A1 (ru) Циклические пептиды-антагонисты cxcr4
EA200701293A1 (ru) Терапевтическая композиция фактора роста кератиноцитов
NO20063393L (no) Farmasoytiske preparater
IS2894B (is) Framleiðsla sómatóstatínpeptíða
EA200400399A1 (ru) Способы лечения легочных заболеваний
WO2003092632A3 (en) Cyclic peptide anti-cancer agents and methods
NO20023357D0 (no) Blanding
ATE282041T1 (de) Aminomethylpyrrolochinazoline als thrombinrezeptor-antagonist
DK1534741T3 (da) Fiberformende peptider i stand til at interagere med selvsamlende peptider
EA200400822A1 (ru) Производные 3,4-дигидро-1h-изохинолин-2-ила